10x Genomics Inc.

AI Score

XX

Unlock

9.18
-0.23 (-2.44%)
At close: Mar 28, 2025, 3:59 PM
9.15
-0.33%
After-hours: Mar 28, 2025, 06:55 PM EDT

Company Description

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific.

The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products.

Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment.

The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence.

It serves various academic, government, biopharmaceutical, biotechnology, and other institutions.

The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

10x Genomics Inc.
10x Genomics Inc. logo
Country United States
IPO Date Sep 12, 2019
Industry Medical - Healthcare Information Services
Sector Healthcare
Employees 1,306
CEO Dr. Serge Saxonov Ph.D.

Contact Details

Address:
6230 Stoneridge Mall Road
Pleasanton, California
United States
Website https://www.10xgenomics.com

Stock Details

Ticker Symbol TXG
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001770787
CUSIP Number 88025U109
ISIN Number US88025U1097
Employer ID 45-5614458
SIC Code 3826

Key Executives

Name Position
Dr. Serge Saxonov Ph.D. Co-Founder, Chief Executive Officer & Director
Adam S. Taich Chief Financial Officer, Treasurer, Principal Financial Officer & Principal Accounting Officer
Alexander Wong Chief Information Officer
Eric S. Whitaker Esq. Chief Legal Officer
Michael Schnall-Levin Founding Scientist & Chief Technology Officer
Rebecca Port Chief People Officer
Cassie Corneau Manager of Investor Relations & Strategic Finance
Dr. Benjamin J. Hindson Ph.D. Co-Founder, President, Chief Scientific Officer & Director
Jim Goodrich Chief of Global Operations
Mennah Moustafa Chief Commercial Officer

Latest SEC Filings

Date Type Title
Mar 19, 2025 4 Filing
Mar 19, 2025 4 Filing
Mar 19, 2025 4 Filing
Mar 04, 2025 4 Filing
Feb 26, 2025 4 Filing
Feb 26, 2025 4 Filing
Feb 25, 2025 4 Filing
Feb 13, 2025 S-8 Filing
Feb 13, 2025 10-K Annual Report
Feb 12, 2025 8-K Current Report